Lung Screening Could Reduce Lung Cancer Deaths
Lung cancer is the leading cause of cancer-related mortality in the UK. Approximately three quarters of patients are diagnosed at a late stage. If detected early, seven out of ten patients could survive for a year or more. It is thus important to to introduce early detection strategies that could help ensure early treatment delivery to patients before they reach an advanced stage of the disease.
See also: NSNs in Lung Cancer Can Be Managed With Annual CT Scan
This study evaluated the long-term psychosocial outcomes of CT screening for lung cancer. More than 4000 men and women aged 50-75 years and at high risk of lung cancer were included in the study. Study participants were assessed two weeks into the study and two years later. Emotional responses to CT lung screening were assessed using measures such as cancer distress, anxiety, depression and satisfaction.
Findings showed that more participants from the group that didn't receive scans were dissatisfied with their decision to participate in the trial. Cancer distress was found to be higher in women, participants under the age of 65 and current smokers, regardless of group allocation.
Study researchers conclude: “Sometimes, fear of medical procedures and the results they might bring can prevent people from seeking life-saving tests. However, what our trial shows is that CT lung cancer screening actually has no long-term negative psychosocial impact on patients, making it an excellent tool for catching lung cancer earlier when there is a better chance of survival.”
Image Credit: Wikimedia Commons
Published on : Mon, 1 Aug 2016
A breakthrough in biopsy efficiency The Brevera system streamlines the entire breast biopsy process from start to finish – with real-time imaging for instant verification and automated post-biopsy specimen handling. This has the potential to...
A better 3D™ breast screening experience – for everyone. The new 3Dimensions™ system is designed to provide higher quality 3D™ images for radiologists, a more comfortable mammography experience for patients and enhanced workflow for technologists....
UltraDrape is an innovative dressing designed for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) that provides dual-action barrier and securement in one.
The SonoSite SII features a new touchscreen user interface with a clinician-driven menu logic that adaptively adjusts to your imaging needs – “what you need, is what you see”. An embedded dual transducer connector allows you to quickly switch between...
Image accuracy in hand The first wireless, handheld breast ultrasound with exceptional breast image quality. Delivers accurate diagnostic images at the point of care. Ideal for quick diagnostic looks, visual confirmations, interventional procedures,...